mRNA Flu Vaccine Tops Standard Shot in Trial

(MedPage Today) — A modified mRNA quadrivalent influenza vaccine was more effective than a standard inactivated quadrivalent influenza vaccine, a randomized phase III trial showed. During the 2022-2023 flu season among people aged 18 to 64, the relative share…